Bio-Rad Laboratories Net Income 2006-2021 | BIO.B

Bio-Rad Laboratories annual/quarterly net income history and growth rate from 2006 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Bio-Rad Laboratories net income for the quarter ending September 30, 2021 was $3.928B, a 198.75% increase year-over-year.
  • Bio-Rad Laboratories net income for the twelve months ending September 30, 2021 was $6.659B, a 89.13% increase year-over-year.
  • Bio-Rad Laboratories annual net income for 2020 was $3.806B, a 116.43% increase from 2019.
  • Bio-Rad Laboratories annual net income for 2019 was $1.759B, a 381.02% increase from 2018.
  • Bio-Rad Laboratories annual net income for 2018 was $0.366B, a 199.07% increase from 2017.
Bio-Rad Laboratories Annual Net Income
(Millions of US $)
2020 $3,806
2019 $1,759
2018 $366
2017 $122
2016 $26
2015 $109
2014 $89
2013 $78
2012 $165
2011 $179
2010 $185
2009 $145
2008 $90
2007 $93
2006 $103
2005 $82
Bio-Rad Laboratories Quarterly Net Income
(Millions of US $)
2021-09-30 $3,928
2021-06-30 $914
2021-03-31 $977
2020-12-31 $839
2020-09-30 $1,315
2020-06-30 $966
2020-03-31 $686
2019-12-31 $553
2019-09-30 $-259
2019-06-30 $599
2019-03-31 $865
2018-12-31 $-829
2018-09-30 $269
2018-06-30 $268
2018-03-31 $657
2017-12-31 $83
2017-09-30 $22
2017-06-30 $5
2017-03-31 $12
2016-12-31 $-23
2016-09-30 $18
2016-06-30 $18
2016-03-31 $12
2015-12-31 $46
2015-09-30 $17
2015-06-30 $28
2015-03-31 $18
2014-12-31 $39
2014-09-30 $12
2014-06-30 $32
2014-03-31 $7
2013-12-31 $30
2013-09-30 $-7
2013-06-30 $35
2013-03-31 $20
2012-12-31 $43
2012-09-30 $43
2012-06-30 $48
2012-03-31 $31
2011-12-31 $60
2011-09-30 $46
2011-06-30 $40
2011-03-31 $33
2010-12-31 $68
2010-09-30 $45
2010-06-30 $38
2010-03-31 $35
2009-12-31 $38
2009-09-30 $39
2009-06-30 $38
2009-03-31 $30
2008-12-31 $-8
2008-09-30 $28
2008-06-30 $43
2008-03-31 $26
2007-12-31 $12
2007-09-30 $28
2007-06-30 $26
2007-03-31 $27
2006-12-31 $17
2006-09-30 $23
2006-06-30 $32
2006-03-31 $31
2005-12-31 $13
2005-09-30 $16
2005-06-30 $18
2005-03-31 $33
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $22.443B $2.546B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $125.010B 7.90
QIAGEN (QGEN) Netherlands $12.357B 20.93
Biohaven Pharmaceutical Holding (BHVN) United States $6.783B 0.00
Arcus Biosciences (RCUS) United States $3.105B 0.00
Emergent Biosolutions (EBS) United States $2.254B 8.10
ADC Therapeutics SA (ADCT) Switzerland $1.478B 0.00
Myovant Sciences (MYOV) United Kingdom $1.368B 0.00
Zymeworks (ZYME) Canada $0.861B 0.00
Ambrx Biopharma (AMAM) United States $0.337B 0.00
SQZ Biotechnologies (SQZ) United States $0.319B 0.00
Enzo Biochem (ENZ) United States $0.162B 15.90